December 24
RevitalVision featured on Healio – Improving vision in Keratoconus patients
The article highlights a recent study published in the American Journal of Ophthalmology, showcasing significant vision improvements in keratoconus patients using RevitalVision’s technology.
The study demonstrates how RevitalVision’s targeted vision training improves functional vision with a long-lasting effect in keratoconus patients who are intolerant to contact lenses and do not achieve good vision with spectacles.
November 24
New published study in the American Journal of Ophthalmology- improving vision in Keratoconus
We are proud to share a recently published independent randomized controlled study demonstrating RevitalVision’s efficacy in improving vision in patients with keratoconus. The study was published in the American Journal of Ophthalmology – September 2024
Read article
October 24
Global Action for Eye Health- World Sight Day 2024
In recognition of World Sight Day on October 10, ITN Business has launched a special program that we are proud to have participated in. The “Global Action for Eye Health” initiative focuses on worldwide efforts to enhance eye health, emphasizes the vital need for action, and features inspiring stories of innovation and impact from around the globe. Check out the RevitalVision video created for this important initiative.
Watch the video
August 2024
RevitalVision has been awarded the winner of the VSP Vision Innovation Challenge
VSP Vision, the leader in delivering access to health-focused vision care, and MATTER, the premier healthcare incubator and innovation hub, announce RevitalVision as the winner of the first-ever VSP Vision Innovation Challenge.
Read the announcement
June 2024
ESA-ISA 2024
We are thrilled to announce that Prof. Yair Morad will be presenting RevitalVision at the ESA-ISA 2024 Joint Meeting of the European and International Strabismological Associations, taking place in Toulouse France 13-15 June.
This event brings together the leading minds in pediatric ophthalmology, strabismus, orthoptic, and binocular vision, to share knowledge, exchange ideas, and explore the latest developments in these areas.
Professor Yair Morad will speak about Adult Amblyopia Treatment, sharing the latest clinical trial results withRevitalVision.
June 2024
RevitalVision on Israel21c
ISRAEL21C interviewed Yair Yahav, CEO of RevitalVision about RevitalVision’s home-based vision training program.
The article beautifully illustrates how our simple home-based brain training technology greatly enhances vision and quality of life for our patients
Read the full article
